The neurobiology and therapeutic potential of multi-targeting β-secretase, glycogen synthase kinase 3β and acetylcholinesterase in Alzheimer's disease

MG Fronza, D Alves, D Praticò, L Savegnago - Ageing research reviews, 2023 - Elsevier
Alzheimer's Disease (AD) is the most common form of dementia, affecting almost 50 million
of people around the world, characterized by a complex and age-related progressive …

Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands

A Iraji, M Khoshneviszadeh, O Firuzi… - Bioorganic …, 2020 - Elsevier
Alzheimer's Disease (AD) is a progressive neurodegenerative disorder that effects 50 million
people worldwide. In this review, AD pathology and the development of novel therapeutic …

Coumarin linked heterocyclic hybrids: a promising approach to develop multi target drugs for Alzheimer's disease

A Husain, K Al Balushi, MJ Akhtar, SA Khan - Journal of Molecular Structure, 2021 - Elsevier
Alzheimer's disease (AD) is a major progressive and perplexing cortical degenerative
disease of the brain in the elderly. It contributes to a significant socioeconomic burden on …

The recent development of donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's agents: highlights from 2010 to 2020

RT Kareem, F Abedinifar, EA Mahmood, AG Ebadi… - RSC …, 2021 - pubs.rsc.org
Dementia is a term used to define different brain disorders that affect memory, thinking,
behavior, and emotion. Alzheimer's disease (AD) is the second cause of dementia that is …

Multi-target directed drugs as a modern approach for drug design towards Alzheimer's disease: an update

M de Freitas Silva, KST Dias, VS Gontijo… - Current Medicinal …, 2018 - benthamdirect.com
Alzheimer's disease (AD) is a progressive multifactorial neurodegenerative disorder.
Currently, no effective treatment is available and this is due to multiple factors involved in …

Donepezil-based central acetylcholinesterase inhibitors by means of a “bio-oxidizable” prodrug strategy: design, synthesis, and in vitro biological evaluation

L Peauger, R Azzouz, V Gembus… - Journal of medicinal …, 2017 - ACS Publications
With the aim of reducing side effects of acetylcholinesterase inhibitors (AChEIs) during
symptomatic treatment of Alzheimer's disease, we report herein a new class of donepezil …

Design, synthesis and biological evaluation of new phthalimide and saccharin derivatives with alicyclic amines targeting cholinesterases, beta-secretase and amyloid …

D Panek, A Więckowska, T Wichur, M Bajda… - European journal of …, 2017 - Elsevier
The complexity of Alzheimer's disease (AD) calls for search of multifunctional compounds as
potential candidates for effective therapy. A series of phthalimide and saccharin derivatives …

Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT6 receptor antagonists. Design, synthesis and biological …

A Więckowska, M Kołaczkowski, A Bucki… - European journal of …, 2016 - Elsevier
As currently postulated, a complex treatment may be key to an effective therapy for
Alzheimer's disease (AD). Recent clinical trials in patients with moderate AD have shown a …

[HTML][HTML] Perspectives for new and more efficient multifunctional ligands for Alzheimer′ s disease therapy

A Zagórska, A Jaromin - Molecules, 2020 - mdpi.com
Despite tremendous research efforts at every level, globally, there is still a lack of effective
drugs for the treatment of Alzheimer′ s disease (AD). The biochemical mechanisms of this …

N‐Benzyl piperidine Fragment in Drug Discovery

A Sharma, M Sharma, SB Bharate - ChemMedChem, 2024 - Wiley Online Library
The N‐benzyl piperidine (N‐BP) structural motif is commonly employed in drug discovery
due to its structural flexibility and three‐dimensional nature. Medicinal chemists frequently …